Clinical Trial Update: Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Xinglou Chengqi Granule for acute ischemic stroke is not yet recruiting, with Dongzhimen Hospital, Beijing listed as sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xinglou Chengqi Granule

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Acute Ischemic Stroke | Phase 2 | Status: NOT_YET_RECRUITING